妊娠期糖尿病管理范式转变:2型糖尿病与妊娠早期高血糖的重要性
该文为2020年Norbert Freinkel奖讲座,指出传统GDM诊断基于24-28周OGTT,但2型糖尿病在妊娠期增加及早期高血糖(未诊断糖尿病或轻于显性糖尿病)与不良妊娠结局风险升高相关。早期高血糖孕妇比24-28周诊断的GDM更胰岛素抵抗,血压、甘油三酯、围产期死亡和新生儿低血糖更高,需更多胰岛素治疗。目前早期GDM诊断标准及现有管理方案的利弊尚不确定,亟需随机对照试验,同时建议 interim 标准和阈值。
要点
- 妊娠早期高血糖(包括未诊断糖尿病和轻于显性糖尿病)与不良妊娠结局风险增加相关。
- 早期高血糖孕妇比24-28周诊断的GDM更胰岛素抵抗,血压、甘油三酯、围产期死亡和新生儿低血糖更高。
- 早期GDM诊断标准及治疗方案的获益与风险尚不确定,亟需随机对照试验。
核心结论
- 妊娠期糖尿病管理需关注2型糖尿病和妊娠早期高血糖,早期高血糖孕妇不良结局风险更高,但诊断标准和治疗方案尚待研究。
研究设计与样本
- 2020年Norbert Freinkel奖讲座,基于HAPO研究及两项GDM治疗随机对照试验的回顾性分析。
主要发现
- 早期高血糖孕妇比24-28周诊断的GDM更胰岛素抵抗,血压、甘油三酯、围产期死亡和新生儿低血糖更高,需更多胰岛素治疗。
- 2型糖尿病在妊娠期增加,需尽早识别未诊断糖尿病。
关键数值与推荐
- 传统GDM诊断基于24-28周口服葡萄糖耐量试验。
- 早期高血糖(prevalent GDM)指从妊娠早期(孕前)存在的轻度高血糖。
临床怎么用
- 建议尽早筛查未诊断糖尿病,对早期高血糖孕妇考虑 interim 标准和药物治疗阈值,可能不同于24-28周GDM标准。
局限性
- 早期GDM诊断标准及现有管理方案的获益与风险尚不确定,缺乏随机对照试验证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
For over 50 years, the diagnosis of gestational diabetes mellitus (GDM) has been based upon an oral glucose tolerance test at 24-28 weeks' gestation. This is the time during pregnancy when insulin resistance is increasing and hyperglycemia develops among those with insufficient insulin secretory capacity to maintain euglycemia. The Hyperglycemia and Adverse Pregnancy Outcomes (HAPO) study and the two major randomized controlled trials of treating GDM are based upon recruitment of women at this time during pregnancy. Meanwhile, the increasing prevalence of type 2 diabetes in pregnancy, with its significant risk of adverse pregnancy outcomes, has led to a need to identify undiagnosed diabetes as near to conception as possible. Screening for undiagnosed diabetes early in pregnancy also identifies women with hyperglycemia less than overt diabetes, yet at increased risk of adverse pregnancy outcomes. Such women are more insulin resistant-with higher blood pressure, triglycerides, perinatal mortality, and neonatal hypoglycemia with a greater need for insulin treatment-than those with GDM diagnosed at 24-28 weeks' gestation. Currently, there is uncertainty over how to diagnose GDM early in pregnancy and the benefits and harms from using the current management regimen. Randomized controlled trials testing the criteria for, and treatment of, GDM early in pregnancy are urgently needed to address this existing equipoise. In the meantime, the importance of early or "prevalent GDM" (i.e., mild hyperglycemia present from early [before] pregnancy) warrants interim criteria and thresholds for medication, which may differ from those in use for GDM diagnosed at 24-28 weeks' gestation.
引用
- Simmons D. Paradigm Shifts in the Management of Diabetes in Pregnancy: The Importance of Type 2 Diabetes and Early Hyperglycemia in Pregnancy: The 2020 Norbert Freinkel Award Lecture. Diabetes Care. 2021. PMID: 33972313. doi:10.2337/dci20-0055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。